Cvs Health INC
Name Change - CVS Caremark is now CVS Health
Based in DC
🤖
AI Overview
With $2.1M in lobbying spend across 26 quarterly filings, Cvs Health INC is a significant lobbying presence. They deploy 13 individual lobbyists
$2.1M
Total Lobbying Spend
26
Quarterly Filings
1
Lobbying Firms Used
13
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $480K |
| 2019 | $360K |
| 2020 | $400K |
| 2021 | $260K |
| 2022 | $150K |
| 2023 | $250K |
| 2025 | $250K |
Lobbying Firms
BOCKORNY GROUP, INC.
What They Lobby For
- Issues related to corporate tax policy reform Issues related to taxes on employee health plans H.R.1 - Tax Cuts and Jobs Act of 2017
- Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 H.R.2212 - CREATES Act of 2017 Judiciary issues related to the drug supply chain
- Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals H.R.2212 - CREATES Act of 2017 Judiciary issues related to the drug supply chain
- Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Judiciary issues related to the drug supply chain Issues related to the company's merger with Aetna Issues related to the "Gag Rule" bill
- Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Judiciary issues related to the drug supply chain Issues related to the company's merger with Aetna Issues related to the "Gag Rule" bill Issues relating to dialysis reimbursements
- Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
- Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages
- Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021
- Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages HR 1319 American Rescue Plan
- Issues related to hospital payments Issues related to hospital inclusion and representation in COVID-19 packages Public Law Number 116-136 CARES Act H.R. 133 Consolidated Appropriations Act, 2021 H.R. 1868 An Act to prevent across-the-board direct spending cuts, and for other purposes HR 5376 Build Back Better Act Budget Reconciliation Legislative Recommendations Relating to Medicaid; Budget Reconciliation Legislative Recommendations Relating to CHIP; Budget Reconciliation Legislative Recommendations Relating to Medicare (Sec. 30801, 30803, 30804, 30805)
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.